Plain-English translation of NCT07069569 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new injection called combined with other hepatitis B treatments in people who already have chronic hepatitis B and are taking antiviral medicines. The study wants to see if adding this medication helps improve outcomes and is safe. Researchers will compare different treatment combinations to find the best approach.
Current hepatitis B treatments help control the virus, but many people don't achieve a complete cure. This trial is exploring whether this new medication, when paired with existing treatments, can help more patients clear the virus or achieve better long-term results.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll receive injections for either 16 or 24 weeks, depending on which group you're assigned to. You may also receive other hepatitis B treatments like pegylated interferon or a as part of your combination therapy. You'll need to visit the clinic regularly for check-ups, blood tests, and liver imaging to monitor how well the treatment is working and check for any side effects.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China